MYL(SH:600993)2023-10-27 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥805,892,792.47, a decrease of 6.00% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2023 was ¥137,010,729.02, reflecting a decline of 4.93% year-on-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥137,186,553.15, down 2.23% from the previous year[6]. - The basic earnings per share for Q3 2023 was ¥0.32, a decrease of 5.88% compared to the same period last year[8]. - The weighted average return on equity for Q3 2023 was 3.75%, a decrease of 0.54 percentage points year-on-year[9]. - Total operating revenue for the first three quarters of 2023 was CNY 2,446,244,490.16, a decrease of 12.2% compared to CNY 2,785,082,784.85 in the same period of 2022[58]. - Net profit for the first three quarters of 2023 was CNY 430,377,694.99, up 3.0% from CNY 415,378,366.07 in 2022[58]. - Operating profit for the first three quarters of 2023 was CNY 514,923,918.12, showing a decrease of 0.1% from CNY 516,432,839.90 in the previous year[67]. - Net profit for the first three quarters of 2023 amounted to CNY 435,579,725.13, down 2.9% from CNY 448,559,710.37 in 2022[67]. Cash Flow - The company reported a net cash flow from operating activities of ¥76,460,034.32, a significant decrease of 70.15% compared to the previous year[6]. - The net cash flow from operating activities for the first three quarters of 2023 was approximately $816.69 million, an increase from $593.45 million in the same period last year[26]. - Cash flow from operating activities generated CNY 76,460,034.32, down 70.1% from CNY 256,136,797.86 in the previous year[60]. - Cash flow from investing activities showed a net outflow of CNY 338,454,110.82, an improvement from a net outflow of CNY 854,636,150.02 in 2022[60]. Assets and Liabilities - Total assets at the end of Q3 2023 amounted to ¥5,010,364,432.83, a decrease of 0.93% from the end of the previous year[9]. - The total liabilities as of Q3 2023 were ¥1,166,024,054.71, down from ¥1,438,754,527.44 in the previous year[14]. - Total assets amounted to approximately $5.06 billion, slightly down from $5.09 billion in the previous year[31]. - The total liabilities increased to approximately $1.57 billion, up from $958.86 million in the previous year, indicating a substantial rise in financial obligations[22]. - Total liabilities amounted to CNY 958.86 million, a slight decrease from the previous period[39]. - Total equity reached CNY 3.58 billion, reflecting a minor decrease compared to the prior period[39]. - The total assets of the company were CNY 4.54 billion, showing a decrease from the previous total[41]. - The company's total liabilities decreased to CNY 3,878,256,731.58 from CNY 3,268,104,952.84 year-over-year[63]. Equity - The company's total equity attributable to shareholders increased by 6.36% year-on-year, reaching ¥3,718,574,863.28[9]. - The total equity attributable to shareholders of the parent company increased to CNY 3,718.57 million from CNY 3,496.24 million, marking an increase of approximately 6.34%[57]. - Total equity attributable to shareholders reached $3,496,240,837.10, slightly up from $3,495,369,462.12[97]. - The company's retained earnings increased to $2,666,691,484.53, compared to $2,665,820,109.55 in the previous period[97]. Investment and Expenses - Investment income increased by 523.93% due to the disposal of equity in Dafu Pharmaceutical[34]. - Research and development expenses decreased to CNY 48,389,153.88 from CNY 59,009,294.92, a decline of 18.0%[58]. - Research and development expenses decreased to CNY 39,492,365.12 in 2023 from CNY 49,180,914.05 in 2022, reflecting a reduction of 19.3%[67]. - The cash received from sales of goods and services was CNY 2,252,491,877.34, down from CNY 2,926,703,844.24 in the previous year[60]. Market Strategy - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the report[45]. - The company plans to continue focusing on market expansion and new product development to drive future growth[68].